跳至主要内容
临床试验/NCT03679156
NCT03679156已完成不适用

Retinal Pigment Epithelial Characteristics in Eyes With Neovascular Age-related Macular Degeneration Following Long-term Treatment With Anti Neovascular Endothelial Growth Factor

Hospital Hietzing0 个研究点目标入组 18 人开始时间: 2016年5月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
18
主要终点
visual acuity

研究概览

简要总结

Purpose:

To assess retinal pigment epithelial (RPE) and retinal structural changes in eyes with neovascular age-related macular degeneration (AMD) treated with anti-vascular endothelial growth factor (anti-VEGF) during long-term follow-up and to evaluate morphological markers potentially influencing prognosis.

Methods:

18 patients (18 eyes) with neovascular AMD were recruited subsequent to completion the Avastin Versus Lucentis in Age Related Macular Degeneration (MANTA) study following a mean period of 84 months (range: 69-93 months). After receiving a loading dose of 3 intravitreal anti-VEGF injections subsequent to baseline of the MANTA study, patients were treated as-needed [pro re nata (PRN)]. Functional and morphological changes were assessed using spectral domain optical coherence tomography (SD-OCT).

研究设计

研究类型
Observational
观察模型
Other
时间视角
Retrospective

入排标准

年龄范围
66 Years 至 98 Years(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Inclusion and exclusion criteria corresponded to the criteria of the MANTA study

排除标准

  • Inclusion and exclusion criteria corresponded to the criteria of the MANTA study

结局指标

主要结局

visual acuity

时间窗: 93 months

visual acuity testing was performed

次要结局

未报告次要终点

研究者

发起方
Hospital Hietzing
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Clara Wernigg

Dr.

Hospital Hietzing

相似试验